Your idea: Build and backtest an intraday options buying strategy on Nifty 50 wit…
One-time — gone on refresh. Copy it and paste as a YouTube comment.
Detected components (auto-read from transcript)
Verdict
Real option-buying backtest. Decoded entry: an EMA crossover on NIFTY 10-min bars → buy the ATM weekly CE (long) / PE (short), stop 30% / target 60% of premium, square-off by 15:15. Priced on real 1-minute NIFTY option premiums (GFDL, 2015–2026 — every tick of theta, IV crush and gamma is inside these prices), real charges and spread.
2,595 trades on ₹1L: net -185.3% over 12 years (-15.4%/yr, loses money), win 40%, payoff 1.39 (avg win ₹2,342 / avg loss ₹-1,681), max drawdown -258%, worst trade ₹-10,325. 2015: ₹-3,385. 2016: ₹-8,195. 2017: ₹-958. 2018: ₹+25,924. 2019: ₹-18,804. 2020: ₹-4,479. 2021: ₹+23,531. 2022: ₹-18,707. 2023: ₹-51,553. 2024: ₹-10,169. 2025: ₹-116,046. 2026: ₹-2,489.
Option buying is convex — low win-rates are normal; the question is whether winners outrun the premium bleed. Backtested on 12 years of minute-level premium data (2015–2026; monthly contracts before 2019 — weeklies didn't exist; constant 65-unit lot); entries tested intraday as taught. Flagged for human review.
Is it profitable? (green above the line = made money, red below = lost it)
Year by year (every trade the rules fired, on real NIFTY option premiums — 1 lot, ₹1L)
| Year | Trades | Win % | Net P&L |
|---|---|---|---|
| 2015 | 108 | 46% | ₹-3,385 |
| 2016 | 176 | 44% | ₹-8,195 |
| 2017 | 198 | 41% | ₹-958 |
| 2018 | 200 | 44% | ₹+25,924 |
| 2019 | 193 | 37% | ₹-18,804 |
| 2020 | 228 | 39% | ₹-4,479 |
| 2021 | 305 | 42% | ₹+23,531 |
| 2022 | 245 | 40% | ₹-18,707 |
| 2023 | 253 | 37% | ₹-51,553 |
| 2024 | 212 | 39% | ₹-10,169 |
| 2025 | 338 | 36% | ₹-116,046 |
| 2026 | 139 | 43% | ₹-2,489 |
Full transcript (440 words)
💬 Trader reviews (traded this? tell others what really happened)
No reviews yet — be the first. Real experiences help other traders more than any backtest.
User opinions, not investment advice. Reviews are moderated before publishing.